Page last updated: 2024-09-04

vatalanib and Aging

vatalanib has been researched along with Aging in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Campochiaro, PA; Hofmann, F; Okamoto, N; Ozaki, H; Ozaki, K; Seo, MS; Wood, JM; Yamada, E; Yamada, H	1

Other Studies

1 other study(ies) available for vatalanib and Aging

Article	Year
Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. The American journal of pathology, 2000, Volume: 156, Issue:2 Topics: Aging; Angiogenesis Inhibitors; Animals; Animals, Newborn; Endothelial Growth Factors; Enzyme Inhibitors; Ischemia; Lymphokines; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neovascularization, Pathologic; Phosphotransferases; Phthalazines; Pyridines; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Retinal Vessels; Rhodopsin; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2000

Article

Year

Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization.

The American journal of pathology, 2000, Volume: 156, Issue:2

Topics: Aging; Angiogenesis Inhibitors; Animals; Animals, Newborn; Endothelial Growth Factors; Enzyme Inhibitors; Ischemia; Lymphokines; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neovascularization, Pathologic; Phosphotransferases; Phthalazines; Pyridines; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Retinal Vessels; Rhodopsin; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2000